Health Trials

Overweight Subject

2

Review clinical trials related to Overweight Subject. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin

The purpose of this study is to characterize the drug-drug intereaction of HDM1002 and metformin, empagliflozin, midazolam, valsartan, and warfarin in overweight/obese adult subjects. The safety and tolerability of HDM1002 with metformin, empagliflozin, midazolam, valsartan, and warfarin when given separately or together will also be evaluated

Participants needed: 111
Trial details
Phase: Phase 1Age: 18-45Biological sex: AllType: InterventionalSponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Updated: Jan 9, 2026Locations: 1
Eligibility criteria

According to the medical history, clinical laboratory test results, vital sign m... [+2]

Subject has a history or family history of medullary thyroid cancer, thyroid C-c... [+10]

Read more
Status: Not yet recruiting

A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects and Overweight Subjects.

The purpose of this study is to characterize the effect of HDM1002 on the PK of single dose of repaglinide, atorvastatin, digoxin and rosuvastatin in healthy adult subjects. The safety and tolerability of HDM1002 with repaglinide, atorvastatin, digoxin and rosuvastatin when given separately or together will also be evaluated.

Participants needed: 30
Trial details
Phase: Phase 1Age: 18-45Biological sex: AllType: InterventionalSponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Updated: Sep 23, 2024Locations: 1
Eligibility criteria

According to the medical history, clinical laboratory test results, vital sign m... [+2]

Subject has a history or family history of medullary thyroid cancer, thyroid C-c... [+8]

Read more